Voltage-temperature charge verification testing of 34 ampere-hour nickel-cadmium cells

This testing was designed to evaluate various voltage-temperature (V-T) charge curves for use in low-Earth-orbit (LEO) applications of nickel-cadmium battery cells. The trends established relating V-T level to utilizable capacity were unexpected. The trends toward lower capacity at higher V-T levels was predominant in this testing. This effect was a function of the V-T level, the temperature, and the cell history. This effect was attributed to changes occurring in the positive plate. The results imply that for some applications, the use of even lower V-T levels may be warranted. The need to limit overcharge, especially in the early phases of missions, is underlined by this test program

Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction.

Soft tissue sarcomas are uncommon tumors, and intraduodenal soft tissue sarcoma manifestation is even more rare. Only three cases of intraduodenal sarcomas have been reported in the literature thus far. Here, we report a case of an intraduodenal recurrence of a retroperitoneal sarcoma causing bowel obstruction. This unusual recurrence pattern likely relates to the patient's previous resection and radiation treatment, and highlights the benefits, limitations and follow-up strategies after multimodality treatment

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors.

All gynecologists are faced with ovarian tumors on a regular basis, and the accurate preoperative diagnosis of these masses is important because appropriate management depends on the type of tumor. Recently, the International Ovarian Tumor Analysis (IOTA) consortium published the Assessment of Different NEoplasias in the adneXa (ADNEX) model, the first risk model that differentiates between benign and four types of malignant ovarian tumors: borderline, stage I cancer, stage II-IV cancer, and secondary metastatic cancer. This approach is novel compared to existing tools that only differentiate between benign and malignant tumors, and therefore questions may arise on how ADNEX can be used in clinical practice. In the present paper, we first provide an in-depth discussion about the predictors used in ADNEX and the ability for risk prediction with different tumor histologies. Furthermore, we formulate suggestions about the selection and interpretation of risk cut-offs for patient stratification and choice of appropriate clinical management. This is illustrated with a few example patients. We cannot propose a generally applicable algorithm with fixed cut-offs, because (as with any risk model) this depends on the specific clinical setting in which the model will be used. Nevertheless, this paper provides a guidance on how the ADNEX model may be adopted into clinical practice

Electric Dipole Radiation from Spinning Dust Grains

We discuss the rotational excitation of small interstellar grains and the resulting electric dipole radiation from spinning dust. Attention is given to excitation and damping of rotation by: collisions with neutrals; collisions with ions; plasma drag; emission of infrared radiation; emission of microwave radiation; photoelectric emission; and formation of H_2 on the grain surface. We introduce dimensionless functions F and G which allow direct comparison of the contributions of different mechanisms to rotational drag and excitation. Emissivities are estimated for dust in different phases of the interstellar medium, including diffuse HI, warm HI, low-density photoionized gas, and cold molecular gas. Spinning dust grains can explain much, and perhaps all, of the 14-50 GHz background component recently observed in CBR studies. It should be possible to detect rotational emission from small grains by ground-based observations of molecular clouds.Comment: 59 pages, 19 eps figures, uses aaspp4.sty . Submitted to Ap.

What\u27s New in Plant Pathology: Resistance: Mystery and Misunderstandings

One of the most common management recommendations for plant diseases is the use of resistant or tolerant varieties/hybrids in your production system. However, there is common confusion on the definition and differentiation of susceptible, tolerant, and resistant varieties/hybrids from a plant pathology viewpoint. A susceptible variety/hybrid allows the pathogen to reproduce and causes significant disease development and in turn compromises the productivity of the plant (i.e., yield). A tolerant variety/hybrid allows the pathogen to reproduce and cause disease at the same or at a slightly reduced rate as a susceptible variety/cultivar; however, there is no noticeable reduction in the plant’s overall productivity. Finally, a resistant variety/hybrid limits or prevents pathogen reproduction and disease development; hence, plant productivity is little or not affected while the plant remains very productive. It is important to note that plant resistance is not plant “immunity,” where it is expected that a variety/hybrid will have NO disease. Unfortunately, immunity does not exist for the majority of plant diseases and expecting such a reaction (or lack thereof) is unrealistic. Resistance, simply, is a reduction in disease severity due to the plant’s defenses. Plants have many mechanisms for defense but do not possess immune systems comparable to our own that preclude infection and disease development

Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study

Background: To compare different ultrasound-based international ovarian tumour analysis (IOTA) strategies and risk of malignancy index (RMI) for ovarian cancer diagnosis using a meta-analysis approach of centre-specific data from IOTA3. Methods: This prospective multicentre diagnostic accuracy study included 2403 patients with 1423 benign and 980 malignant adnexal masses from 2009 until 2012. All patients underwent standardised transvaginal ultrasonography. Test performance of RMI, subjective assessment (SA) of ultrasound findings, two IOTA risk models (LR1 and LR2), and strategies involving combinations of IOTA simple rules (SRs), simple descriptors (SDs) and LR2 with and without SA was estimated using a meta-analysis approach. Reference standard was histology after surgery. Results: The areas under the receiver operator characteristic curves of LR1, LR2, SA and RMI were 0.930 (0.917–0.942), 0.918 (0.905–0.930), 0.914 (0.886–0.936) and 0.875 (0.853–0.894). Diagnostic one-step and two-step strategies using LR1, LR2, SR and SD achieved summary estimates for sensitivity 90–96%, specificity 74–79% and diagnostic odds ratio (DOR) 32.8–50.5. Adding SA when IOTA methods yielded equivocal results improved performance (DOR 57.6–75.7). Risk of Malignancy Index had sensitivity 67%, specificity 91% and DOR 17.5. Conclusions: This study shows all IOTA strategies had excellent diagnostic performance in comparison with RMI. The IOTA strategy chosen may be determined by clinical preference